Cohen & Steers, Inc. (CNS) P/E Ratio History
Fairly ValuedTrading at 25.1x, near 5Y avg of 24.6x · 55th percentile · In line with own history · Data 2004–2025
Loading P/E history...
P/E Ratio Analysis
As of June 21, 2026, Cohen & Steers, Inc. (CNS) trades at a price-to-earnings ratio of 25.1x, with a stock price of $74.88 and trailing twelve-month earnings per share of $2.97.
The current P/E is roughly in line with its 5-year average of 24.6x. Over the past five years, CNS's P/E has ranged from a low of 14.9x to a high of 35.8x, placing the current valuation at the 55th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.6x, CNS trades at a 85% premium to its sector peers. The sector includes 783 companies with P/E ratios ranging from 0.0x to 196.5x.
The PEG ratio of 1.84 (P/E divided by 0% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, CNS trades roughly in line with the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CNS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CNS Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CNS P/E vs Peers
Traditional active asset managers peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $948M | 7.1Lowest | 0.48 | +18% | |
| $6B | 21.3 | 2.96 | -7% | |
| $473M | 9.8 | 1.18 | +14% | |
| $81M | 8.1 | 2.19 | +38% | |
| $17B | 36.3 | - | +7% | |
| $9B | 15.5 | 0.39Best | +50%Best | |
| $3B | 8.9 | 2.49 | +11% | |
| $6B | 17.3 | 1.53 | +3% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CNS Historical P/E Data (2004–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Dec 31 2025 | $62.78 | $2.98 | 21.1x | -50% |
| FY2025 Q3 | - | $65.61 | $3.19 | 20.6x | -52% |
| FY2025 Q2 | Jun 30 2025 | $75.35 | $3.15 | 23.9x | -44% |
| FY2025 Q1 | Mar 31 2025 | $80.25 | $3.06 | 26.2x | -38% |
| FY2024 Q4 | - | $92.34 | $2.97 | 31.1x | -27% |
| FY2024 Q3 | Sep 30 2024 | $95.95 | $2.68 | 35.8x | -16% |
| FY2024 Q2 | Jun 30 2024 | $72.56 | $2.56 | 28.3x | -33% |
| FY2024 Q1 | Mar 31 2024 | $76.89 | $2.57 | 29.9x | -30% |
| FY2023 Q4 | Dec 31 2023 | $75.73 | $2.60 | 29.1x | -32% |
| FY2023 Q3 | Sep 30 2023 | $62.69 | $2.66 | 23.6x | -45% |
| FY2023 Q2 | Jun 30 2023 | $57.99 | $2.91 | 19.9x | -53% |
| FY2023 Q1 | Mar 31 2023 | $63.96 | $3.33 | 19.2x | -55% |
| FY2022 Q4 | Dec 31 2022 | $64.56 | $3.47 | 18.6x | -56% |
| FY2022 Q3 | Sep 30 2022 | $62.63 | $4.11 | 15.2x | -64% |
| FY2022 Q2 | - | $63.59 | $4.26 | 14.9x | -65% |
| FY2022 Q1 | - | $85.89 | $4.15 | 20.7x | -51% |
| FY2021 Q4 | Dec 31 2021 | $92.51 | $4.30 | 21.5x | -49% |
| FY2021 Q3 | - | $83.77 | $2.91 | 28.8x | -32% |
| FY2021 Q2 | Jun 30 2021 | $82.09 | $2.52 | 32.6x | -23% |
| FY2021 Q1 | Mar 31 2021 | $65.33 | $2.16 | 30.2x | -29% |
| FY2020 Q4 | - | $74.30 | $1.58 | 47.0x | +11% |
| FY2020 Q3 | Sep 30 2020 | $55.74 | $2.42 | 23.0x | -46% |
| FY2020 Q2 | - | $68.05 | $2.46 | 27.7x | -35% |
| FY2020 Q1 | - | $45.45 | $2.52 | 18.0x | -58% |
| FY2019 Q4 | - | $62.76 | $2.78 | 22.6x | -47% |
| FY2019 Q3 | Sep 30 2019 | $54.93 | $2.57 | 21.4x | -50% |
| FY2019 Q2 | Jun 30 2019 | $51.44 | $2.52 | 20.4x | -52% |
| FY2019 Q1 | Mar 31 2019 | $42.27 | $2.50 | 16.9x | -60% |
| FY2018 Q4 | Dec 31 2018 | $34.32 | $2.41 | 14.2x | -67% |
| FY2018 Q3 | Sep 30 2018 | $40.61 | $2.30 | 17.7x | -58% |
| FY2018 Q2 | Jun 30 2018 | $41.71 | $2.18 | 19.1x | -55% |
| FY2018 Q1 | Mar 31 2018 | $40.66 | $2.05 | 19.8x | -53% |
| FY2017 Q4 | Dec 31 2017 | $47.29 | $1.95 | 24.3x | -43% |
| FY2017 Q3 | Sep 30 2017 | $39.49 | $2.08 | 19.0x | -55% |
| FY2017 Q2 | Jun 30 2017 | $40.54 | $2.06 | 19.7x | -54% |
| FY2017 Q1 | Mar 31 2017 | $39.97 | $2.09 | 19.1x | -55% |
| FY2016 Q4 | Dec 31 2016 | $33.60 | $1.99 | 16.9x | -60% |
| FY2016 Q3 | Sep 30 2016 | $42.75 | $1.56 | 27.4x | -36% |
| FY2016 Q2 | - | $40.44 | $1.42 | 28.5x | -33% |
| FY2016 Q1 | - | $38.92 | $1.34 | 29.0x | -32% |
| FY2015 Q4 | - | $30.48 | $1.40 | 21.8x | -49% |
| FY2015 Q3 | Sep 30 2015 | $27.45 | $1.61 | 17.0x | -60% |
| FY2015 Q2 | - | $34.08 | $1.64 | 20.8x | -51% |
| FY2015 Q1 | - | $40.95 | $1.68 | 24.4x | -43% |
| FY2014 Q4 | Dec 31 2014 | $42.08 | $1.66 | 25.3x | -40% |
| FY2014 Q3 | - | $38.44 | $1.75 | 22.0x | -48% |
| FY2014 Q2 | Jun 30 2014 | $43.38 | $1.76 | 24.6x | -42% |
| FY2014 Q1 | Mar 31 2014 | $39.85 | $1.61 | 24.8x | -42% |
| FY2013 Q4 | - | $40.06 | $1.52 | 26.4x | -38% |
| FY2013 Q3 | Sep 30 2013 | $35.31 | $1.58 | 22.3x | -47% |
| FY2013 Q2 | Jun 30 2013 | $33.98 | $1.40 | 24.3x | -43% |
| FY2013 Q1 | Mar 31 2013 | $36.07 | $1.42 | 25.4x | -40% |
| FY2012 Q4 | Dec 31 2012 | $30.47 | $1.49 | 20.4x | -52% |
| FY2012 Q3 | Sep 30 2012 | $29.62 | $1.37 | 21.6x | -49% |
| FY2012 Q2 | Jun 30 2012 | $34.51 | $1.36 | 25.4x | -40% |
| FY2012 Q1 | Mar 31 2012 | $31.90 | $1.36 | 23.5x | -45% |
| FY2011 Q4 | Dec 31 2011 | $28.90 | $1.25 | 23.1x | -46% |
| FY2011 Q3 | Sep 30 2011 | $28.75 | $1.18 | 24.4x | -43% |
| FY2011 Q2 | - | $33.15 | $1.26 | 26.3x | -38% |
| FY2011 Q1 | - | $29.68 | $1.17 | 25.4x | -40% |
| FY2010 Q4 | Dec 31 2010 | $26.10 | $1.08 | 24.2x | -43% |
| FY2010 Q3 | - | $21.70 | $1.05 | 20.7x | -51% |
| FY2010 Q2 | Jun 30 2010 | $20.74 | $0.93 | 22.3x | -48% |
| FY2010 Q1 | Mar 31 2010 | $24.96 | $0.51 | 48.9x | +15% |
| FY2008 Q4 | Dec 31 2008 | $10.99 | $0.43 | 25.4x | -40% |
| FY2008 Q3 | - | $28.33 | $1.04 | 27.2x | -36% |
| FY2008 Q2 | Jun 30 2008 | $25.97 | $1.45 | 17.9x | -58% |
| FY2008 Q1 | Mar 31 2008 | $26.49 | $1.57 | 16.9x | -60% |
| FY2007 Q4 | Dec 31 2007 | $29.97 | $1.78 | 16.8x | -60% |
| FY2007 Q3 | Sep 30 2007 | $37.03 | $1.72 | 21.5x | -49% |
| FY2007 Q2 | Jun 30 2007 | $43.45 | $1.74 | 25.0x | -41% |
| FY2007 Q1 | Mar 31 2007 | $43.08 | $0.35 | 123.1x | +189% |
| FY2006 Q4 | Dec 31 2006 | $40.17 | $0.05 | 803.4x | +1789% |
| FY2006 Q1 | Mar 31 2006 | $24.50 | $0.84 | 29.2x | -31% |
| FY2005 Q4 | Dec 31 2005 | $18.63 | $0.80 | 23.3x | -45% |
| FY2005 Q3 | Sep 30 2005 | $20.00 | $0.84 | 23.8x | -44% |
| FY2005 Q2 | - | $20.61 | $0.04 | 515.3x | +1111% |
| FY2005 Q1 | - | $16.50 | $0.15 | 110.0x | +159% |
| FY2004 Q4 | Dec 31 2004 | $16.25 | $0.32 | 50.8x | +19% |
| FY2004 Q3 | - | $15.44 | $0.34 | 45.4x | +7% |
Average P/E for displayed period: 42.5x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
22+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CNS — Frequently Asked Questions
Quick answers to the most common questions about buying CNS stock.
What is CNS's P/E ratio?
Cohen & Steers, Inc. (CNS) trailing twelve-month P/E ratio is 25.1x, based on TTM diluted EPS of $2.97. The 5-year average P/E is 24.6x and the historical range spans 14.9x to 35.8x.
Is CNS stock overvalued or undervalued?
CNS trades at 25.1x P/E, near its 5-year average of 24.6x. The 55th percentile ranking within the 14.9x–35.8x historical range places valuation within normal bounds.
Is CNS stock expensive?
CNS is fairly valued relative to its own history. The current P/E of 25.1x is near the 5-year average of 24.6x (55th percentile of historical range).
What is CNS's historical P/E range?
Over the past 5 years, CNS's P/E ratio has ranged from 14.9x to 35.8x, with a median of 23.9x and an average of 24.6x. The current P/E of 25.1x places the stock at the 55th percentile of this range. Full historical data spans 2004–2025.
How does CNS's P/E compare to the S&P 500?
CNS trades at 25.1x P/E versus the S&P 500 median of 24.4x. The 3% premium to the market typically reflects higher expected earnings growth or quality.
How does CNS's valuation compare to Financial Services peers?
Cohen & Steers, Inc. P/E of 25.1x compares to the Financial Services sector median of 13.6x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CNS's PEG ratio?
CNS PEG ratio is 1.84, based on a P/E of 25.1x and EPS growth of 0.3%. A PEG between 1 and 2 suggests valuation aligns with growth expectations — typically considered fair.
What is CNS's earnings yield?
CNS earnings yield is 3.98%, the inverse of its 25.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.